Thursday, June 12, 2008
« oooh baby it's the nerd girls | Main | NETS-T »
FDA Drug Safety Newsletter
In This Issue


Postmarketing Reviews

PemetrexedReports of radiation recall associated with pemetrexed (marketed as ALIMTA) NatalizumabReports of serious liver injury associated with natalizumab (marketed as TYSABRI)

CarbamazepineReports of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with carbamazepine (marketed as CARBATROL, EQUETRO, TEGRETOL and other associated generics) in Asians positive for the HLA-B*1502 allele
New Molecular Entity (NME) - 3 Years Later
Feature Article

Drug Safety CommunicationsList of advisories on drug safety posted on FDA’s Web site from January 1, 2008 through April 30, 2008, with related links
NetHappenings Mailing List | Science
Thursday, June 12, 2008 1:22:00 PM (Pacific Daylight Time, UTC-07:00)    Disclaimer  |   |  Related posts:
Fair Use The Google Scholar service has been extended so that users can choose to search legal opinions and journals for information that they need.
The Bipartisan Breast Cancer Patient Protection Act Needs Your Support!
Tweet Black Friday Deals
How do you Upgrade Planet Earth by Marcus Ranum
Microsoft's Bing search engine has a vulnerability with its cash-back promotion, which impacts both merchants and customers.
Barak Obama's half brother is Jewish